Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer

Journal of the National Cancer Institute

Volumn 106, Issue 3, 2014, Pages

  Kadara, Humam ^a   Fujimoto, Junya ^a   Yoo, Suk Young ^a   Maki, Yuho ^a   Gower, Adam C ^b   Kabbout, Mohamed ^a   Garcia, Melinda M ^a   Chow, Chi Wan ^a   Chu, Zuoming ^a   Mendoza, Gabriella ^a   Shen, Li ^a   Kalhor, Neda ^a   Hong, Waun Ki ^a   Moran, Cesar ^a   Wang, Jing ^a   Spira, Avrum ^b   Coombes, Kevin R ^a   Wistuba, Ignacio I ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYSOSOMAL PROTEIN TRANSMEMBRANE 4 BETA; MESSENGER RNA; NEUROPILIN; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; LAPTM4B PROTEIN, HUMAN; MEMBRANE PROTEIN; NETO2 PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR; VIPR1 PROTEIN, HUMAN;

ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MALE; PRIORITY JOURNAL; TRANSCRIPTOMICS; UPREGULATION; ADULT; AGED; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; METHODOLOGY; MICROARRAY ANALYSIS; MIDDLE AGED; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SMOKING;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MICROARRAY ANALYSIS; MIDDLE AGED; NEOPLASM STAGING; ONCOGENE PROTEINS; PROTEIN-SERINE-THREONINE KINASES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; SMOKING; TRANSCRIPTOME; UP-REGULATION;

EID: 84898717571     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju004     Document Type: Article

References (38)

1. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953;6(5):963-968.
2. Auerbach O, Stout AP, Hammond EC, et al. Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. N Engl J Med. 1961;265(6):253-267.
3. Braakhuis BJ, Tabor MP, Kummer JA, et al. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 2003;63(8):1727-1730.
4. Gomperts BN, Spira A, Massion PP, et al. Evolving concepts in lung carcinogenesis. Semin Respir Crit Care Med. 2011;32(1):32-43.
5. Graham TA, McDonald SA, Wright NA. Field cancerization in the GI tract. Future Oncol. 2011;7(8):981-993.
6. Kadara H, Wistuba II. Field cancerization in non-small cell lung cancer: implications in disease pathogenesis. Proc Am Thorac Soc. 2012;9(2):38-42.
7. Gold KA, Kim ES, Lee JJ, et al. The BATTLE to personalize lung cancer prevention through reverse migration. Cancer Prev Res (Phila). 2011;4(7):962-972.
8. Wistuba, II, Behrens C, Milchgrub S, et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene. 1999;18(3):643-650.
9. Wistuba II, Behrens C, Virmani AK, et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res. 2000;60(7):1949-1960.
10. Wistuba, II, Gazdar AF. Lung cancer preneoplasia. Annu Rev Pathol. 2006;1:331-348.
11. Belinsky SA, Nikula KJ, Palmisano WA, et al. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci U S A. 1998;95(20):11891-11896.
12. Belinsky SA, Palmisano WA, Gilliland FD, et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res. 2002;62(8):2370-2377.
13. Nelson MA, Wymer J, Clements N Jr. Detection of K-ras gene mutations in non-neoplastic lung tissue and lung cancers. Cancer Lett. 1996;103(1):115-121.
14. Tang X, Shigematsu H, Bekele BN, et al. EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients. Cancer Res. 2005;65(17):7568-7572.
15. Beane J, Sebastiani P, Liu G, et al. Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression. Genome Biol. 2007;8(9):R201.
16. Spira A, Beane J, Shah V, et al. Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc Natl Acad Sci U S A. 2004;101(27):10143-10148.
17. Spira A, Beane JE, Shah V, et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med. 2007;13(3):361-366.
18. Gustafson AM, Soldi R, Anderlind C, et al. Airway PI3K pathway activation is an early and reversible event in lung cancer development. Sci Transl Med. 2010;2(26):26ra25.
19. Kadara H, Shen L, Fujimoto J, et al. Characterizing the molecular spatial and temporal field of injury in early-stage smoker non-small cell lung cancer patients after definitive surgery by expression profiling. Cancer Prev Res (Phila). 2013;6(1):8-17.
20. Behrens C, Lin HY, Lee JJ, et al. Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancer. Clin Cancer Res. 2008;14(19):6014-6022.
21. Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4(2):249-264.
22. Bull SB. Sample size and power determination for a binary outcome and an ordinal exposure when logistic regression analysis is planned. Am J Epidemiol. 1993;137(6):676-684.
23. Molaei M, Mansoori BK, Mashayekhi R, et al. Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions? BMC Cancer. 2010;10(October 2010):537.
24. Perez-Ortiz M, Gutierrez PA, Hervas-Martinez C. Projection-based ensemble learning for ordinal regression. IEEE Trans Cybern. 2013; doi:10.1109/TCYB. 2013.2266336.
25. Pounds S, Morris SW. Estimating the occurrence of false positives and false negatives in microarray studies by approximating and partitioning the empirical distribution of p-values. Bioinformatics. 2003;19(10):1236-1242.
26. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545-15550.
27. Li L, Wei XH, Pan YP, et al. LAPTM4B: a novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling. Oncogene. 2010;29(43):5785-5795.
28. Zhou BB, Peyton M, He B, et al. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell. 2006;10(1):39-50.
29. Kaklamani VG, Pasche B. Role of TGF-beta in cancer and the potential for therapy and prevention. Expert Rev Anticancer Ther. 2004;4(4):649-661.
30. Borczuk AC, Kim HK, Yegen HA, et al. Lung adenocarcinoma global profiling identifies type II transforming growth factor-beta receptor as a repressor of invasiveness. Am J Respir Crit Care Med. 2005;172(6):729-737.
31. Borczuk AC, Sole M, Lu P, et al. Progression of human bronchioloalveolar carcinoma to invasive adenocarcinoma is modeled in a transgenic mouse model of K-ras-induced lung cancer by loss of the TGF-beta type II receptor. Cancer Res. 2011;71(21):6665-6675.
32. Sreedharan SP, Huang JX, Cheung MC, et al. Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene. Proc Natl Acad Sci U S A. 1995;92(7):2939-2943.
33. Calicchio ML, Collins T, Kozakewich HP. Identification of signaling systems in proliferating and involuting phase infantile hemangiomas by genomewide transcriptional profiling. Am J Pathol. 2009;174(5):1638-1649.
34. Horak CE, Lee JH, Elkahloun AG, et al. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2. Cancer Res. 2007;67(15):7238-7246.
35. Li Y, Zhang Q, Tian R, et al. Lysosomal transmembrane protein LAPTM4B promotes autophagy and tolerance to metabolic stress in cancer cells. Cancer Res. 2011;71(24):7481-7489.
36. Yang H, Xiong F, Qi R, et al. LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinoma. J Surg Oncol. 2010;101(5):363-369.
37. Yin M, Li C, Li X, et al. Over-expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer. J Surg Oncol. 2011;104(1):29-36.
38. Mutz KO, Heilkenbrinker A, Lonne M, et al. Transcriptome analysis using next-generation sequencing. Curr Opin Biotechnol. 2013;24(1):22-30.